Particle
.news
Finance
❯
Investments
❯
Mergers and Acquisitions
Novartis
MorphoSys
6 ARTICLES
last yr.
Novartis Acquires MorphoSys for $2.9 Billion, Expanding Cancer Drug Portfolio